← FDA Drug Approvals (Drugs@FDA)

VYBRIQUE

NDA · New Drug Application · Sponsor: IBSA · Approved 2025-12-16

Drug application

FDA Application #
NDA210858
Application type
New Drug Application
Brand name
VYBRIQUE
Generic name
SILDENAFIL CITRATE
Active ingredients
SILDENAFIL CITRATE
Dosage form
FILM
Route
ORAL
Marketing status
Prescription
Sponsor
IBSA
Manufacturer
IBSA Pharma Inc.
First approval
2025-12-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown